2nd Annual

Metabolic Medicine Summit 2026

|


view programarrow icon

Discover the highlights of the event

connect with usarrow icon

Get your questions answered by our team

become a partnerarrow icon

Join as a sponsor and reserve your booth

Meet Our Featured Speakers

Arjun Channi

Arjun Channi

Sanofi

Close icon
Namrita Negi

Namrita Negi

Deloitte

Arjun Channi

Arjun Channi

Sanofi

Christian Rubio

Christian Rubio

EverythingALS

THE FORUM FOR METABOLIC MEDICINE AND TREATMENT DEVELOPMENT

Welcome to the Metabolic Medicine Summit 2026, an event that brings together industry leaders and healthcare innovators committed to advancing metabolic therapies, technologies, and clinical strategies that are shaping the future of metabolic health.

Metabolic medicine faces significant challenges in turning advancements in gene editing, biomarkers, and precision therapies into meaningful clinical outcomes. This summit will highlight innovative approaches that aim to improve patient care and treatment.

Join us to gain practical insights, connect with global leaders, and help shape the future of metabolic health through innovation and collaboration.

key topics for

Emerging trends in metabolic therapies and patient-centered care

Innovative precision therapies targeting individual metabolic needs, along with patient-centered care models, are transforming treatment strategies worldwide.

Advancing in biomarker-driven research to enhance clinical outcomes

Biomarker research supports precise, effective treatments by identifying disease-specific markers that enhance outcomes and personalize care.

Case studies and clinical trials on therapies for metabolic disorders

Clinical trial data and case studies demonstrate the safety, effectiveness, and real-world impact of emerging therapies for metabolic disorders.

Breakthrough in therapeutic approaches for obesity and metabolic disorders

Advanced therapies for obesity and related metabolic dysfunctions use emerging drug platforms to improve health outcomes.

Innovations in biosimilars and peptide drugs for advanced treatments

Biosimilars and peptides provide cost-effective alternatives, as well as innovative therapies, for managing complex metabolic disorders.

Shaping metabolic medicine with global compliance and regulatory standards

New guidelines ensure the safety, effectiveness, and quality of metabolic therapies, aligning treatment practices with global standards to improve patient care and outcomes.

0

INDUSTRY TOPICS

0

NETWORKING EVENTS

0

LEADING EXPERTS

0

Q&A SESSIONS

Latest News

  • MARKET TRENDS

    2 Sep 2025

    First Generic GLP-1 for Weight Loss Sparks New Battle in US Market
  • PARTNERSHIPS

    29 Aug 2025

    Novo Nordisk Bets $550M on RNA's Next Act
  • TECHNOLOGY

    21 Aug 2025

    AI Joins the Fight Against Obesity
  • REGULATORY

    17 Aug 2025

    Conditional FDA Approval Puts Wegovy on Watch

The Next Obesity Breakthrough Could Be Written in Code

The Next Obesity Breakthrough Could Be Written in Code

INSIGHTS

14 Aug 2025

Eli Lilly partners with Superluminal to tap Al for faster obesity drug discovery beyond injectables.

they've attended our events

Image 1Image 2
Image 1Image 2
Image 1Image 2
Image 1Image 2

Expert Speakers

Vanessa Navarro

Danaher Corporation

Arjun Channi

Sanofi

Gulen Tonga

Tessera Therapeutics

Show more Speakers

Past Attendees

Danaher Corporation

Sanofi

Becton Dickinson

Tessera Therapeutics

Charles River

Inovio

Seran BioScience

Körber

Chiesi USA, Inc.

Show more Attendees

hidden text

subscribe for updates

hidden text

our sponsors

arrow icon
Orlance Inc - Brand final_23starpharma_logoEnvoya_logo_algae (2)Hogne-logo@4x
arrow icon

related events in the series